Synthesis of cysteine flanked collagen-mimetic peptides (CMPs)
Invention Summary:
Hydrogels are essential tools which can mimic extracellular matrix environments; however, current systems lack precise molecular-level control over crosslinking density and porosity. Conventional approaches utilize non-specific, generic biopolymers with statistical or random crosslinking of polymer chains. These approaches offer limited control and poor reproducibility resulting in significant variation between batches. Chemical crosslinking agents offer greater precision in controlling crosslinking density; however these agents can be cytotoxic and reduce biocompatibility of the hydrogel.
Rutgers researchers have created a modular platform to address the need for customizable hydrogel systems which accurately mimic native collagen structures for use in tissue engineering and disease modeling. This platform employs full-length recombinant collagen-like peptides (CLPs), which along with site-specific thiol-maleimide couplings precisely tune crosslinking density and matrix porosity. This system enables versatile mechanical and biochemical control advancing regenerative medicine and ECM-mimetic material design.
Market Applications:
Advantages:
Publications:
Intellectual Property & Development Status: Provisional application filed. Patent pending. Available for licensing and/or research collaboration. For any business development and other collaborative partnerships, contact: marketingbd@research.rutgers.edu